Using Transcranial Alternating Current Stimulation With Starstim Home Device to Improve Executive Function in Youths With 22q11.2 Deletion Syndrome: A Randomized Double-blind Sham-controlled Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this project is to explore the effects of transcranial alternating current stimulation (tACS) in children, adolescents and young adults with a 22q11.2 microdeletion. The main aim of the present research project is to investigate the effects of repeated, individually tuned high-density (HD) tACS on cognition (i.e., WM performance) and related neuroimaging markers in carriers of the 22q11DS. As cognitive deficits, most notably WM impairment, are among the earliest signs of psychotic disorders, interventions during adolescence aimed at reducing cognitive decline in at-risk individuals may prove effective in delaying or even preventing the later emergence of psychotic symptoms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 25
Healthy Volunteers: f
View:

• Confirmed genetic diagnosis of 22q11DS

• Age between 14 and 25 years old

• Willingness to participate

• Informed Consent signed by the subject and/or the caregiver(s)

Locations
Other Locations
Switzerland
University of Geneva
RECRUITING
Geneva
Time Frame
Start Date: 2023-10-20
Estimated Completion Date: 2025-08
Participants
Target number of participants: 40
Treatments
Active_comparator: Active group
Participants will receive 20 sessions of In-phase online theta tACS paired with working memory training.
Sham_comparator: Control group
Participants will receive 20 sessions of sham tACS paired with working memory training. After unblinding (by someone from our lab but external to the study), they will receive 20 sessions of in-phase offline theta tACS.
Related Therapeutic Areas
Sponsors
Leads: Stephan Eliez

This content was sourced from clinicaltrials.gov